相关实验视频

Updated: May 14, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

商业电离室阵列与扫描的质子束的特性,用于MRI引导的质子疗法的应用

Benjamin Gebauer^1,2, Sebastian Gantz^1,3, Daniela Kunath^1,3

¹OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

Medical physics

|May 13, 2025

概括

奥克塔维斯1500电离室阵列适用于MRI引导的质子疗法. 这种剂量计工具准确地测量了磁场内的剂量分布,用于光束的表征和质量保证.

科学领域:

医学物理医学物理
辐射瘤学辐射瘤学

背景情况:

整合MRI指导与质子疗法是一个关键的研究领域.
精确的剂量计算和治疗计划需要在MRI引导的质子疗法中考虑磁场.
剂量计工具对于描述剂量分布和在磁场内执行质量保证至关重要.

研究的目的:

为了描述PTW Octavius 1500电离室阵列的特征.
评估其作为剂量测量工具的适用性,用于MRI导向质子疗法的光束特征和质量保证.

主要方法:

对剂量速率反应,反应均性和有效测量深度的实验性表征.
用马分析进行患者特异性质量保证测试.
在磁性 (B) 射线内MRI扫描仪中的测量,包括参考扫描模式和患者治疗计划.

主要成果:

检测器显示线性剂量速率响应到一个指定的极限.
确定有效的测量深度,响应均性适合治疗计划验证.
用磁场和没有磁场进行了令人满意的患者特异性质量保证测试,在MRI扫描仪内获得了合理的结果.

结论:

奥克塔维斯1500电离室阵列适用于MRI引导质子疗法的剂量测量应用.
实验性表征和测试证实了其在这种先进处理方式中用于光束表征和质量保证的实用性.

关键词:

磁共振成像指导指南电离室阵列是一个电离室阵列.质子疗法是一种质子疗法.

更多相关视频

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Published on: May 9, 2014

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...